Retrospective Study
Copyright ©The Author(s) 2021.
World J Clin Cases. Nov 26, 2021; 9(33): 10088-10097
Published online Nov 26, 2021. doi: 10.12998/wjcc.v9.i33.10088
Table 2 Comparison of clinicopathological characteristics between < 10 mm and ≥ 10 mm tumors in total cohort T1 colorectal cancers (n = 1152)

< 10 mm (n = 116)
≥ 10 mm (n = 1036)
P value
Age, yr66.8 ± 11.566.4 ± 11.60.72
Sex (male/female)84 (72.4)/32 (27.6)645 (62.3)/391 (37.7)0.03
Location (left-sided/right-sided)77 (66.4)/39 (33.6)710 (68.5)/326 (31.5)0.67
Tumor size (mm)7.5 ± 1.222.5 ± 12.60.08
Polypoid/non-polypoid growth (polypoid/non-polypoid)50 (43.1)/66 (56.9)664 (64.1)/372 (35.9)< 0.01
Adenomatous component (±)34 (29.3)/82 (70.7)432 (41.7)/604 (58.3)< 0.01
Morphology(flat/ protruded/ depressed)10 (8.6)/46 (39.7)/60 (51.7)387 (37.4)/429 (41.4)/220 (21.2)< 0.01
Initial treatment (endoscopic/surgical)86 (74.1)/30 (25.9)624 (60.2)/412 (39.8)< 0.01
Surgical resection173 (62.9)/43 (37.1)725 (70.0)/311 (30.0)0.14
Depth of invasion (T1b/T1a)72 (62.1)/44 (37.9)754 (72.8)/282 (27.2)0.02
Histological grade (Por or Muc2/tub1 or tub2)3 (2.6)/113 (97.4)55 (5.3)/981 (94.7)0.26
Vascular invasion (±)35 (30.2)/81 (69.8)287 (27.7)/749 (72.3)0.59
Lymphatic invasion (±)38 (32.8)/78 (67.2)304 (29.3)/732 (70.7)0.45
Tumor budding (BD 2 or 3/BD 1)24 (20.7)/92 (79.3)218 (21.0)/818 (79.0)1.00